This story originally ran on Aug. 17.

Agilent officials this week attributed 25 percent year-over-year growth in the company's liquid chromatography business to strong sales of its 1200 Infinity LC product line.

Agilent President and CEO Bill Sullivan said during a conference call to discuss the company's fiscal third-quarter financial results that the growth was driven by sales of the 1290 Infinity LC, which "continues to exceed expectations," and the recently introduced 1260 Infinity and 1220 Infinity systems.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.